NEW ORLEANS–(BUSINESS WIRE)–Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a
partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces
that KSF has commenced an investigation into Pfizer Inc. (NYSE: PFE).
On August 10, 2017 the Company disclosed that the U.S. Department of
Justice was investigating its wholly-owned subsidiary, Greenstone,
advising investors that “[w]e believe this is related to an ongoing
antitrust investigation of the generic pharmaceutical industry.”
Recently, the Company was among those sued in a wide-ranging lawsuit
brought by 44 state attorneys general alleging an illegal conspiracy to
inflate prices of more than 100 generic drugs, sometimes by more than
1,000%, and stifle competition.
KSF’s investigation is focusing on whether Pfizer’s officers and/or
directors breached their fiduciary duties to Pfizer’s shareholders or
otherwise violated state or federal laws.
If you have information that would assist KSF in its investigation, or
have been a long-term holder of Pfizer shares and would like to discuss
your legal rights, you may, without obligation or cost to you, call
toll-free at 1-877-515-1850 or email KSF Managing Partner Lewis Kahn ([email protected]),
or visit https://www.ksfcounsel.com/cases/nyse-pfe/
to learn more.
About Kahn Swick & Foti, LLC
KSF, whose partners include the Former Louisiana Attorney General
Charles C. Foti, Jr., is a law firm focused on securities, antitrust and
consumer class actions, along with merger & acquisition and breach of
fiduciary litigation against publicly traded companies on behalf of
shareholders. The firm has offices in New York, California and Louisiana.
To learn more about KSF, you may visit www.ksfcounsel.com.
Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner